Open Peer Review Reports for: Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
Pre-publication versions of this article are available by contacting info@biomedcentral.com.
Original Submission | ||
---|---|---|
2 Aug 2016 | Submitted | Original manuscript |
29 Aug 2016 | Reviewed | Reviewer Report - Wajd Al-Holou |
17 Sep 2016 | Reviewed | Reviewer Report - Kallesh Danappa Jayappa |
26 Oct 2016 | Author responded | Author comments - Peter Mudry |
Resubmission - Version 2 | ||
26 Oct 2016 | Submitted | Manuscript version 2 |
27 Nov 2016 | Reviewed | Reviewer Report - Kallesh Danappa Jayappa |
28 Nov 2016 | Reviewed | Reviewer Report - Wajd Al-Holou |
10 Jan 2017 | Author responded | Author comments - Peter Mudry |
Resubmission - Version 3 | ||
10 Jan 2017 | Submitted | Manuscript version 3 |
Resubmission - Version 4 | ||
Submitted | Manuscript version 4 | |
23 Jan 2017 | Author responded | Author comments - Peter Mudry |
Resubmission - Version 5 | ||
23 Jan 2017 | Submitted | Manuscript version 5 |
30 Jan 2017 | Author responded | Author comments - Peter Mudry |
Resubmission - Version 6 | ||
30 Jan 2017 | Submitted | Manuscript version 6 |
Publishing | ||
4 Feb 2017 | Editorially accepted | |
10 Feb 2017 | Article published | 10.1186/s12885-017-3115-x |
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.
You can find further information about the peer review system here.